France 2030 Budget: €54B ▲ Total allocation | Deployed: €35B+ ▲ 65% of total | Companies Funded: 4,200+ ▲ +800 in 2025 | Startups Funded: 850+ ▲ +150 in 2025 | Competitions: 150+ ▲ 12 currently open | Gigafactories: 15+ ▲ In construction | Jobs Created: 100K+ ▲ Direct employment | Battery Capacity: 120 GWh ▲ 2030 target | H2 Electrolyzers: 6.5 GW ▲ 2030 target | Nuclear SMRs: 6+ ▲ In development | Regions: 18 ▲ All covered | France 2030 Budget: €54B ▲ Total allocation | Deployed: €35B+ ▲ 65% of total | Companies Funded: 4,200+ ▲ +800 in 2025 | Startups Funded: 850+ ▲ +150 in 2025 | Competitions: 150+ ▲ 12 currently open | Gigafactories: 15+ ▲ In construction | Jobs Created: 100K+ ▲ Direct employment | Battery Capacity: 120 GWh ▲ 2030 target | H2 Electrolyzers: 6.5 GW ▲ 2030 target | Nuclear SMRs: 6+ ▲ In development | Regions: 18 ▲ All covered |

Definition

The CNRS (Centre National de la Recherche Scientifique — National Center for Scientific Research) is France’s primary public research organization and the largest research institution in Europe, with approximately 32,000 employees including 11,000 researchers, 14,000 engineers and technicians, and thousands of doctoral and post-doctoral researchers. The CNRS operates more than 1,100 joint research units (Unités Mixtes de Recherche — UMR) embedded within French universities and engineering schools, covering all scientific disciplines from fundamental mathematics and physics to chemistry, life sciences, environmental sciences, and digital technologies. It is the institutional backbone of France’s scientific research capacity.

Role in France 2030

The CNRS is the foundational research institution upon which France 2030’s entire commercialization agenda depends. France 2030 cannot fund companies producing quantum computers, advanced biotherapeutics, or next-generation semiconductor materials if those companies’ core technologies were not first developed in publicly funded research institutions — primarily the CNRS and its research units.

CNRS researchers are directly involved in France 2030’s most ambitious technology bets. Quantum computing company Pasqal was co-founded by Nobel laureate Alain Aspect and Christophe Salomon, both CNRS researchers, building on CNRS laboratory work in quantum optics. AI companies including Kyutai draw on researchers with deep CNRS institutional ties. Bioproduction technologies being commercialized by French biotech companies emerged from INSERM and CNRS joint research units.

Under France 2030’s PEPR (Priority Research Programs) framework, the CNRS participates in and often leads major multi-institution research programs in quantum computing, AI, materials for energy transition, marine research, and others. These PEPRs channel France 2030 funds directly to CNRS research units, ensuring that the fundamental science underlying France 2030’s industrial objectives continues to advance.

Key Facts

  • Approximately 32,000 total staff including 11,000 researchers
  • Over 1,100 joint research units (UMR) embedded in French universities
  • Europe’s largest public research organization by staff count
  • Nobel laureates affiliated: significant — including Alain Aspect (quantum physics, 2022), Serge Haroche (quantum optics, 2012)
  • Annual budget: approximately €3.3 billion
  • Participates in all France 2030 PEPR priority research programs
  • Joint research units at all major French universities: Sorbonne, ENS, Polytechnique, INSA, etc.

Why It Matters

For anyone investing in or partnering with French deep tech companies, understanding the CNRS’s role as the scientific bedrock is essential. The most technically credible French deep tech companies — particularly in quantum computing, advanced materials, AI hardware, and biotechnology — trace their core technology to CNRS research units. Due diligence on these companies necessarily involves evaluating the CNRS research from which they emerged and the ongoing relationship between the company and the CNRS laboratory.

CNRS licensing agreements, joint laboratory arrangements, and doctoral training partnerships are structural advantages for French deep tech companies that their foreign counterparts often lack: access to thousands of frontier researchers and the latest laboratory equipment, without the capital cost of maintaining a fully independent research operation. France 2030 is designed to commercialize this structural advantage at industrial scale.

Premium Intelligence

Access premium analysis for this section.

Subscribe →